# Understanding the Exopher:  A Novel Mechanism for Extrusion of Neurotoxic Contents

> **NIH NIH R01** · RUTGERS, THE STATE UNIV OF N.J. · 2020 · $614,746

## Abstract

Basic research can inform on mechanisms relevant to late onset neurodegenerative disease and suggest
avenues of treatment. Healthy aging of the brain requires meticulous maintenance of protein
synthesis/folding/degradation systems, and this capacity is often disrupted in neurodegenerative disease.
Recently it has come to be appreciated that diseased neurons can produce toxic products like aggregated
proteins that can be taken up by neighboring cells—there is speculation that this mechanism might be involved
in disease spread within the brain. How neurons generate and send out extracellular material in vivo is a
question that must be addressed as we consider therapeutic intervention.
We study the aging nervous system in the simple animal model C. elegans, in which individual neurons, as
well as labeled protein aggregates within them, can easily be visualized in the living organism. We have
unexpectedly discovered that some C. elegans neurons can extrude large packets we call “exophers”. The
contents of these dramatically expelled exophers can contain introduced human disease protein aggregates.
Multiple approaches to exaggerating protein-folding stresses in those neurons, including over-expressing
human Alzheimer’s disease fragment Ab1-42 or Huntington’s disease-associated polyQ protein, and genetically
or pharmacologically impairing branches of protein homeostasis, increase exopher formation. Aggregated
proteins extruded in exophers travel through a neighboring cell, which we think attempts to degrade the
expelled neurotoxic aggregates, but the non-degradable trash can pass through to be taken up by distant cells.
We hypothesize that exopher production is a previously unrecognized alternative route for adult neurons to
clear protein aggregates. We speculate that this mechanism, and the associated mechanism of release and
uptake by surrounding cells, is conserved across species and may be analogous to currently unknown
mechanisms operating in human brain relevant to neurodegenerative disease.
We propose to exploit the considerable advantages of the C. elegans model system (transparent body, easy
genetic manipulation, exquisitely defined nervous system, powerful cell biology, short lifespan) to advance
understanding of exopher biology. Our goals are to: 1) define the genetic and cell biological events that are
critical for exopher formation by probing motors, cytoskeletal factors and membrane trafficking agents that we
know are important; 2) learn about the exodus of the extruded exopher as it transits though neighboring
tissues, defining how the invading exopher is recognized, reacted to, and, if resistant, thrown out again.
Our work should inform on a novel pathway of proteostasis control relevant to both healthy brain aging and
neurodegenerative disease, defining a new area for study and for development of clinical interventions.

## Key facts

- **NIH application ID:** 9821175
- **Project number:** 5R01AG047101-07
- **Recipient organization:** RUTGERS, THE STATE UNIV OF N.J.
- **Principal Investigator:** MONICA A. DRISCOLL
- **Activity code:** R01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $614,746
- **Award type:** 5
- **Project period:** 2013-09-30 → 2022-11-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/9821175

## Citation

> US National Institutes of Health, RePORTER application 9821175, Understanding the Exopher:  A Novel Mechanism for Extrusion of Neurotoxic Contents (5R01AG047101-07). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/9821175. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*